Sernova Corp (SEOVF) 0.2639 $SEOVF Sernova Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sernova Corp (SEOVF) 0.2639 $SEOVF

Sernova Announces First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update
Marketwired - Tue Mar 15, 5:01AM CDT
Sernova Corp. (TSX VENTURE: SVA)(OTCQB: SEOVF)(FRANKFURT: PSH), a clinical stage company developing medical technologies for the long-term treatment of chronic diseases including diabetes and hemophilia, announced today its financial results for the three months ending January 31, 2016 and provided an overview of recent Company highlights.
SVA.VN: 0.290 (-0.010)

Sernova Honoured as Member of the "2016 TSX Venture 50" and Ranked #4 in Life Sciences and Clean Technologies
Marketwired - Fri Feb 05, 5:00AM CST
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a clinical stage company developing medical technologies for the long-term treatment of chronic diseases including diabetes and hemophilia, announced today it has received the ranking of fourth in the category of Life Sciences and Clean Technologies and has been selected as member of the "2016 TSX Venture 50" Companies. This is a prestigious group of top market performers from among the 1,791 companies listed on the Toronto Venture Exchange as of December 31, 2015.
SVA.VN: 0.290 (-0.010)

Sernova Announces Agreement With CCRM to Produce Specialized Cells for the Treatment of Diabetes
Marketwired - Tue Jan 26, 5:01AM CST
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a clinical stage company developing medical technologies for the long-term treatment of chronic diseases including diabetes and hemophilia, announced today it has entered into a service agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to establish, optimize and validate Sernova's licensed technology for creating stem cell derived therapeutic cells that produce insulin and are glucose responsive.
SVA.VN: 0.290 (-0.010)

BUYINS.NET: SVA, AT, CAB, BMRN, CLMT, SWI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jan 06, 6:48AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Sernova Corp (NASDAQ:SVA), ATLANTIC POWER CORP (NYSE:AT), CABELAS INCORPORATED (NYSE:CAB), BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), Calumet Specialty Products Partners LP (NASDAQ:CLMT), SolarWinds Inc (NYSE:SWI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AT: 2.47 (-0.07), SWI: 59.98 (unch), BMRN: 91.99 (-1.53), CAB: 50.39 (-0.04), SVA: 5.93 (unch), CLMT: 5.65 (+0.09)

Sernova Corp to Present at the Biotech Showcase(TM) 2016 in San Francisco on January 13, 2016
Marketwired - Wed Jan 06, 5:12AM CST
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a clinical stage regenerative medicine company, today announced that Dr. Philip Toleikis, Sernova's President and CEO, will be providing a corporate update at the 8th annual Biotech Showcase Conference in San Francisco, CA, at 4:00 p.m. PST on January 13, 2016 in San Francisco, California. In a full roster of business development meetings, Dr. Toleikis will also be updating key pharma and institutional audiences on the company's progress and future plans.
SVA.VN: 0.290 (-0.010)

Sernova Awarded Europe's Prestigious Horizon 2020 Grant to Fund Development of Cell-Based Hemophilia Therapeutic Product Into the Clinic
Marketwired - Mon Dec 21, 5:01AM CST
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a clinical stage regenerative medicine company, announced today that the European Commission's Horizon 2020 program has awarded a EUR5.6M ($8.5M CAD) grant to a consortium consisting of Sernova Corp. and five European academic and private partners to advance development of a GMP clinical grade Factor VIII releasing therapeutic cell product in combination with Sernova's Cell Pouch(TM) for the treatment of severe hemophilia A, a serious genetic bleeding disorder caused by missing or defective factor VIII in the blood stream.
SVA.VN: 0.290 (-0.010)

SeeThruEquity Initiates Coverage on Sernova Corp. (TSX: SVA, OTCQB: SEOVF) with a Price Target of CAD $0.76
ACCESSWIRE - Mon Oct 05, 8:03AM CDT
NEW YORK, NY / ACCESSWIRE / October 5, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it recently initiated coverage of Sernova Corp. (TSX: SVA, OTCQB: SEOVF) with a Price Target of CAD $0.76.

BUYINS.NET: SVA, TKC, BKF, VC, PRTS, GXC Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 29, 8:10AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Sernova Corp (NASDAQ:SVA), Turkcell Iletisim Hizmetleri AS (NYSE:TKC), iShares MSCI BRIC Index Fund (NYSE:BKF), Visteon Corp (NYSE:VC), US Auto Parts Network Inc (NASDAQRTS), SPDR S&P China ETF (NYSE:GXC) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
VC: 70.58 (+0.11), PRTS: 4.29 (+0.10), TKC: 8.58 (+0.01), SVA: 5.93 (unch), GXC: 77.73 (-0.16), BKF: 33.74 (-0.01)

Sernova Announces Listing on OTCQB Exchange
Marketwired - Mon Sep 21, 3:01PM CDT
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH)(OTCQB: SEOVF), a leading clinical stage, regenerative medicine company developing biologically compatible, implantable medical device and therapeutic cellular technologies is pleased to announce it has been listed for trading on the OTCQB market exchange in the United States under the symbol "SEOVF".
SVA.VN: 0.290 (-0.010)

Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies
Marketwired - Thu Sep 10, 5:01AM CDT
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH), a clinical stage company developing medical technologies for the long-term treatment of chronic metabolic diseases including diabetes, blood disorders such as haemophilia and other diseases, announced today it has signed a license agreement with the University Health Network (UHN) of Toronto, Canada to gain exclusive worldwide rights to certain patent-pending technologies developed by distinguished UHN researchers, Dr. Cristina Nostro and Dr. Gordon Keller. These technologies relate to the development of stem cells into glucose-responsive therapeutic cells for the treatment of patients with insulin-dependent diabetes.
SVA.VN: 0.290 (-0.010)

Sernova Corp. Announces Collaboration with Massachusetts General Hospital to Develop Novel Diabetes Treatment with Funding Support from JDRF
Marketwired - Tue Jul 07, 5:01AM CDT
Sernova Corp. (TSX VENTURE: SVA)(FRANKFURT: PSH), is pleased to announce a research collaboration with Massachusetts General Hospital, supported with funding from JDRF to develop a novel treatment for diabetes.
SVA.VN: 0.290 (-0.010)

Sernova Grants Stock Options
Marketwired - Fri Jun 26, 4:01PM CDT
SERNOVA CORP. (the "Company" (TSX VENTURE: SVA) announces that, in accordance with the Company's 2015 Incentive Plan, it has granted a total of 625,000 deferred share units to its directors and a total of 2,460,000 incentive stock options to certain officers, employees and consultants of the Company, each such option being exercisable into a common share at a price of $0.26 per share on or before June 25, 2025.
SVA.VN: 0.290 (-0.010)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TDH's First-Half Revenue Grew, but Margins Vanished

Updated Category News Views 106

A rental business can add tenants and still march backward, and TDH Holdings just demonstrated the ugly math. For the six months ended June 30, 2026, revenue from continuing operations rose 26.45% to $0.74 million. That is the pleasant number, and it deserves exactly one polite nod. Everything beneath it looks far less comfortable: costs climbed faster than revenue, gross...

Continue Reading
Texas Plumbing Award Signals Local Service Discipline

Updated Category News Views 90

A clogged main line is not glamorous, but it is where a local service reputation gets tested for real. Neighborhood Plumbing and Drain has been named a 2026 Best of Texas Award winner in the Plumbing Contractors category, a recognition that matters less as a trophy than as a public signal: customers around Central Texas have noticed the outfit. For anyone watching the...

Continue Reading
Caregiver Strategy Puts a Hard Truth on the Table Today

Updated Category News Views 57

Sixty-three million people carrying care responsibilities is not a side issue; it is a national load-bearing wall. The 2026 National Strategy to Support Family Caregivers arrives with that reality plainly in view, and frankly, it is overdue for the country to treat family care as core infrastructure rather than a private household problem somebody is expected to absorb...

Continue Reading
BET's HBCU Basketball Bet Is Bigger Than Six Games

Updated Category News Views 46

December television usually hands the microphone to the same old basketball machinery, which makes BET putting HBCU hoops in primetime feel overdue rather than merely promotional. Beginning December 3 at 8:00 p.m. ET, BET and Straight Shooter Media will air a six-game series built around Howard University and a rotating slate of opponents. The opener is Grambling State...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
Jeff Stern Turns Travel Photography Into a Sensory Memoir

Updated Category News Views 112

Frost in a mountain tent, fermented mare’s milk in a yurt, and coffee in Vietnamese rice paddies are doing more work here than a thousand polished sunset captions ever could. Jeff Stern’s A Change of Scenery, released by Palmetto Publishing on November 17, 2026, comes from a man who spent more than 25 years building brands and then decided the usual labels around...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 118

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 15

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading
Saban Center Partnership Gives Health Learning a Lift

Updated Category News Views 82

A dinosaur race may sound like pure kid bait, but the underlying idea is sturdier than that. Cardiac Solutions and the Seale family are backing an interactive health-and-performance exhibit at Tuscaloosa’s planned Saban Center, a project intended to turn questions about movement, fitness, heart rate and oxygen levels into something children can actually touch, test and...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 108

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading

Top 5 Most Recently Viewed Articles

Spectral Medical Secures $3 Million Funding for Growth

Updated Category News Views 100

Spectral Medical Secures a $3 Million Funding Boost In a significant development, Spectral Medical Inc. has successfully secured a $3 million advance through a collaboration with Vantive US Healthcare LLC. This funding serves as a vital resource for Spectral, a company dedicated to enhancing therapeutic treatments for sepsis and septic shock. Strengthening Financial...

Continue Reading
Exploring the Thriving Hyperscale Data Center Industry

Updated Category News Views 192

Hyperscale Data Centers: A Market on the Move The global hyperscale data center market is set to expand quickly, with projections pointing to USD 177.58 billion in the coming years, up from USD 111.57 billion in the previous year. From 2024 to 2032, forecasts call for a compound annual growth rate (CAGR) of 5.3%. Behind that curve: rising demand for cloud services, rapid...

Continue Reading
Stock Market Sees Positive Gains Amid Mixed Economic Sentiment

Updated Category News Views 122

Stock Market Overview and Performance The Fear and Greed index indicates stability in market perceptions, remaining in the "Neutral" zone despite fluctuations. On the latest trading day, U.S. stocks demonstrated an upward trend, specifically highlighting a surge of over 300 points in the Dow Jones index during this session. Key Stock Performances Particularly notable were...

Continue Reading
Peyto Exploration Declares Monthly Dividend for November 2025

Updated Category News Views 161

Peyto Exploration & Development Corp. Announces Dividend Details CALGARY, Alberta — Peyto Exploration & Development Corp. (TSX: PEY) proudly announces that its monthly dividend of $0.11 per common share will be disbursed on November 14, 2025. This payment is dedicated to shareholders who are on record as of October 31, 2025. Understanding the Dividend Payment The...

Continue Reading
Investors Alert: Rentokil Initial Class Action Lawsuit Details

Updated Category News Views 333

Rentokil Initial Class Action Lawsuit Overview In a recent development, investors holding American Depositary Shares (ADSs) in Rentokil Initial plc are being notified of an impending deadline in a securities class action lawsuit. Those who have suffered losses exceeding $100,000 can apply to be lead plaintiffs. The deadline for filing these applications is January 27,...

Continue Reading